127 related articles for article (PubMed ID: 1281040)
1. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Masood S; Sim SJ; Lu L
Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
[TBL] [Abstract][Full Text] [Related]
2. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
3. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
Gottlieb C; Raju U; Greenwald KA
Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
[TBL] [Abstract][Full Text] [Related]
4. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
5. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
Joshi MG; Lee AK; Pedersen CA; Schnitt S; Camus MG; Hughes KS
Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
[TBL] [Abstract][Full Text] [Related]
6. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
[TBL] [Abstract][Full Text] [Related]
7. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
8. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
9. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
[TBL] [Abstract][Full Text] [Related]
10. Stages on the way to breast cancer.
Going JJ
J Pathol; 2003 Jan; 199(1):1-3. PubMed ID: 12474219
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of keratin expression and actin distribution in benign and malignant mammary diseases.
Wada T; Yasutomi M; Yamada K; Hashimura K; Kunikata M; Tanaka T; Huang JW; Mori M
Anticancer Res; 1991; 11(6):1983-93. PubMed ID: 1723260
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast.
Kawaguchi K; Shin SJ
Am J Surg Pathol; 2012 Jul; 36(7):1009-20. PubMed ID: 22446941
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study in breast carcinoma. S100-protein positive cells and neuroendocrine differentiation.
Zółtowska A; Moszkowska G; Zamorska B; Roszkiewicz A
Arch Immunol Ther Exp (Warsz); 1996; 44(4):271-7. PubMed ID: 9017169
[TBL] [Abstract][Full Text] [Related]
14. Breast pathology practice: most common problems in a consultation service.
Putti TC; Pinder SE; Elston CW; Lee AH; Ellis IO
Histopathology; 2005 Nov; 47(5):445-57. PubMed ID: 16241992
[TBL] [Abstract][Full Text] [Related]
15. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
16. In-situ lobular/myoepithelial neoplasia of the breast.
Shousha S; Knee G
Histopathology; 2004 Jul; 45(1):93-5. PubMed ID: 15228454
[No Abstract] [Full Text] [Related]
17. Characterization by image cytometry of duct epithelial proliferative disease of the breast.
King EB; Chew KL; Hom JD; Duarte LA; Mayall B; Miller TR; Neuhaus JM; Wrensch MR; Petrakis NL
Mod Pathol; 1991 May; 4(3):291-6. PubMed ID: 1712475
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
Grin A; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2009 Nov; 33(11):1615-23. PubMed ID: 19675450
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
20. Benign proliferative lesions and in situ carcinoma of the breast: new immunohistological findings and their biological implications.
Böcker W; Bier B; Ludwig A; de Hesselle B; Gerdes J
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():41-9. PubMed ID: 7507748
[No Abstract] [Full Text] [Related]
[Next] [New Search]